790
Views
46
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Spinal cord markers in ALS: Diagnostic and biomarker considerations

, , , , &
Pages 407-415 | Received 09 Nov 2011, Accepted 11 Dec 2011, Published online: 13 Feb 2012

References

  • Ryberg H, Bowser R. Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev Proteomics. 2008;5:249–62.
  • Grosskreutz J, Peschel T, Unrath A, Dengler R, Ludolph AC, Kassubek J. Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders. Amyotroph. Lateral Scler. 2008;9:238–48.
  • Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009; 8:94–109.
  • Turner MR, Grosskreutz J, Kassubek J, Abrahams S, Agosta F, Benatar M, . Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:400–3.
  • Agosta F, Absinta M, Sormani MP, Ghezzi A,Bertolotto A, Montanari E, . In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain. 2007;130:2211–9.
  • Facon D, Ozanne A, Fillard P, Lepeintre JF, Tournoux-Facon C, Ducreux D. MR Diffusion Tensor Imaging and Fiber Tracking in Spinal Cord Compression. AJNR Am J Neuroradiol. 2005;26:1587–94.
  • Ellingson BM, Ulmer JL, Kurpad SN, Schmit BD. Diffusion Tensor MR Imaging in Chronic Spinal Cord Injury. AJNR Am J Neuroradiol. 2008;29:1976–82.
  • Sagiuchi T, Iida H, Tachibana S, Kusumi M, Kan S, Fujii K. Case report: diffusion-weighted MRI in anterior spinal artery stroke of the cervical spinal cord. J Comput Assist Tomogr. 2003;27:410–4.
  • Ducreux D, Lepeintre JF, Fillard P, Loureiro C, Tadie M, Lasjaunias P. MR Diffusion Tensor Imaging and Fiber Tracking in 5 Spinal Cord Astrocytomas. AJNR Am J Neuroradiol. 2006;27:214–6.
  • Agosta F, Rovaris M, Benedetti B, Valsasina P, Filippi M, Comi G. Diffusion tensor MRI of the cervical cord in a patient with syringomyelia and multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004;75:1647-1647.
  • Renoux J, Facon D, Fillard P, Huynh I, Lasjaunias P, Ducreux D. MR Diffusion Tensor Imaging and Fiber Tracking in Inflammatory Diseases of the Spinal Cord. AJNR Am J Neuroradiol. 2006;27:1947–51.
  • Ozanne A, Krings T, Facon D, Fillard P, Dumas JL, Alvarez H, . MR Diffusion Tensor Imaging and Fiber Tracking in Spinal Cord Arteriovenous Malformations: A Preliminary Study. AJNR Am J Neuroradiol. 2007;28:1271–9.
  • Agosta F, Rocca MA, Valsasina P, Sala S, Caputo D, Perini M. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2009;80:53–5.
  • Lin X, Tench CR, Turner B, Blumhardt LD, Constantinescu CS. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon b-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry. 2003;74:1090–4.
  • Wilson JM, Petrik MS, Grant SC, Blackband SJ, Lai J, Shaw CA. Quantitative measurement of neurodegeneration in an ALS-PDC model using MR microscopy. Neuroimage. 2004;23:336–43.
  • Underwood CK, Kurniawan ND, Butler TJ, Cowin GJ, Wallace RH. Non-invasive diffusion tensor imaging detects white matter degeneration in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Neuroimage. 2011; 55:455–61.
  • Choi JK, K stermann E, Dedeoglu A, Jenkins BG. Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation. Eur J Neurosci. 2009;30:2143–50.
  • Choi JK, Dedeoglu A, Jenkins BG. Longitudinal monitoring of motor neuron circuitry in FALS rats using in vivo phMRI. Neuroreport. 2010;21:157–62.
  • Iwasaki Y, Kinoshita M, Ikeda K, Takamiya K, Shiojima T. MRI in patients with amyotrophic lateral sclerosis: correlation with clinical features. Int J Neurosci. 1991;59:253–8.
  • Waragai M. MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology. 1997;39:847–51.
  • Karitzky J, Ludolph AC. Imaging and neurochemical markers for diagnosis and disease progression in ALS. J Neurol Sci. 2001;191:35–41.
  • Waragai M, Shinotoh H, Hayashi M, Hattori T. High signal intensity on T1 weighted MRI of the anterolateral column of the spinal cord in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1997;62:88–91.
  • Terao S, Sobue G, Yasuda T, Kachi T, Takahashi M, Mitsuma T. Magnetic resonance imaging of the corticospinal tracts in amyotrophic lateral sclerosis. J Neurol Sci. 1995; 133:66–72.
  • Thorpe JW, Moseley IF, Hawkes CH, MacManus DG, McDonald WI, Miller DH. Brain and spinal cord MRI in motor neuron disease, J Neurol Neurosurg Psychiatry. 1996;61:314–7.
  • Furby J, Hayton T, Anderson V, Altmann D, Brenner R, Chataway J, . Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis. Mult Scler. 2008;14:1068–75.
  • Lundell H, Barthelemy D, Skimminge A, Dyrby TB, Biering-S rensen F, Nielsen JB. Independent spinal cord atrophy measures correlate to motor and sensory deficits in individuals with spinal cord injury. Spinal Cord. 2011;49:70–5.
  • Freund PA, Dalton C, Wheeler-Kingshott CA, Glensman J, Bradbury D, Thompson AJ, . Method for simultaneous voxel-based morphometry of the brain and cervical spinal cord area measurements using 3D-MDEFT. J Magn Reson Imaging. 2010;32:1242–7.
  • Sperfeld AD, Bretschneider V, Flaith L, Unrath A, Hanemann CO, Ludolph AC, . MR-Pathologic Comparison of the Upper Spinal Cord in Different Motor Neuron Diseases. Eur Neurol. 2005;53:74–7.
  • Valsasina P, Agosta F, Benedetti B, Caputo D, Perini M, Salvi F, . Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78:480–4.
  • Agosta F, Rocca MA, Valsasina P, Sala S, Caputo D, Perini M, . A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2009;80:53–5.
  • Nair G, Carew JD, Usher S, Lu D, Hu XP, Benatar M. Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis. Neuroimage. 2010;53:576–83.
  • Cohen-Adad J, Descoteaux M, Rossignol S, Hoge RD, Deriche R, Benali H. Detection of multiple pathways in the spinal cord using Q-ball imaging. Neuroimage. 2008;42:739–49.
  • Dowell NG, Jenkins TM, Ciccarelli O, Miller DH, Wheeler-Kingshott CA. Contiguous-slice zonally oblique multislice (CO-ZOOM) diffusion tensor imaging: examples of in vivo spinal cord and optic nerve applications. J Magn Reson Imaging. 2009;29:454–60.
  • Cohen-Adad J, El Mendili MM, Leh ricy S, Pradat PF, Blancho S, Rossignol S, . Demyelination and degeneration in the injured human spinal cord detected with diffusion and magnetization transfer MRI. Neuroimage. 2011;55: 1024–33.
  • Unrath A, Ludolph AC, Kassubek J. Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol. 2007;254: 1099–106.
  • Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport. 1998;9:1757–61.
  • Kalra S, Genge A, Arnold DL. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:22–6.
  • Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:141–9..
  • Cwik VA, Hanstock CC, Allen PS, Martin WR. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology. 1998;50:72–7.
  • Pioro EP, Majors AW, Mitsumoto H, Nelson DR, Ng TC. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology. 1999;53:71–9.
  • Abe K, Takanashi M, Watanabe Y, Tanaka H, Fujita N, Hirabuki N, . Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology. 2001;43:537–41.
  • Pohl C, Block W, Karitzky J, Träber F, Schmidt S, Grothe C, . Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol. 2001;58:729–35.
  • Henning A, Sch r M, Kollias SS, Boesiger P, Dydak U. Quantitative magnetic resonance spectroscopy in the entire human cervical spinal cord and beyond at 3T. Magn Reson Med. 2008;59:1250–8.
  • Carew JD, Nair G, Pineda-Alonso N, Usher S, Hu X, Benatar M. Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:185–91.
  • Carew JD, Nair G, Andersen PM, Wuu J, Gronka S, Hu X, . Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS. Neurology. 2011;77:1370–5.
  • Stanton BR, Williams VC, Leigh PN, Williams SC, Blain CR, Jarosz JM, . Altered cortical activation during a motor task in ALS. Evidence for involvement of central pathways. J Neurol. 2007;254:1260–7.
  • Palmieri A, Naccarato M, Abrahams S, Bonato M, D'Ascenzo C, Balestreri S, . Right hemisphere dysfunction and emotional processing in ALS: an fMRI study. J Neurol. 2010;257:1970–8.
  • Abrahams S, Goldstein LH, Simmons A, Brammer M, Williams SC, Giampietro V, . Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain. 2004;127:1507–17.
  • Mohammadi B, Kollewe K, Samii A, Krampfl K, Dengler R, M nte TF. Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol. 2009;217:147–53.
  • Malisza KL, Stroman PW. Functional imaging of the rat cervical spinal cord. J Magn Reson Imaging. 2002; 16:553–8.
  • Stroman PW, Krause V, Malisza KL, Frankenstein UN, Tomanek B. Functional magnetic resonance imaging of the human cervical spinal cord with stimulation of different sensory dermatomes. Magn Reson Imaging. 2002; 20:1–6.
  • Strowman PW, Kornelsen J, Lawrence J. An improved method for spinal functional MRI with large volume coverage of the spinal cord. J Magn Reson Imaging. 2005; 21:520–6.
  • Brooks JC, Beckmann CF, Miller KL, Wise RG, Porro CA, Tracey I, . Physiological noise modelling for spinal functional magnetic resonance imaging studies. Neuroimage. 2008;39:680–92.
  • Figley CR, Stroman PW. Development and validation of retrospective spinal cord motion time-course estimates (RESPITE) for spin-echo spinal fMRI: improved sensitivity and specificity by means of a motion-compensating general linear model analysis. Neuroimage. 2009;44:421–7.
  • Piché M, Cohen-Adad J, Nejad MK, Perlbarg V, Xie G, Beaudoin G, . Characterization of cardiac-related noise in fMRI of the cervical spinal cord. Magn Reson Imaging. 2009;27:300–10.
  • Bouwman CJ, Wilmink JT, Mess WH, Backes WH. Spinal cord functional MRI at 3 T: gradient echo echo-planar imaging versus turbo spin echo. Neuroimage. 2008;43:288–96.
  • Stroman PW, Tomanek B, Krause V, Frankenstein UN, Malisza KL. Mapping of neuronal function in the healthy and injured human spinal cord with spinal fMRI. Neuroimage. 2002;17:1854–60.
  • Madi S, Flanders AE, Vinitski S, Herbison GJ, Nissanov J. Functional MR imaging of the human cervical spinal cord. AJNR Am J Neuroradiol. 2001;22:1768–74.
  • Bouwman CJ, Wilmink JT, Mess WH, Backes WH. Spinal cord functional MRI at 3 T: gradient echo echo-planar imaging versus turbo spin echo. Neuroimage. 2008;43:288–96.
  • Kornelsen J, Stroman PW. fMRI of the lumbar spinal cord during a lower limb motor task. Magn Reson Med. 2004;52:411–4.
  • Agosta F, Valsasina P, Caputo D, Stroman PW, Filippi M. Tactile-associated recruitment of the cervical cord is altered in patients with multiple sclerosis. Neuroimage. 2008;39: 1542–8.
  • Stroman PW, Kornelsen J, Bergman A, Krause V, Ethans K, Malisza KL, . Non-invasive assessment of the injured human spinal cord by means of functional magnetic resonance imaging. Spinal Cord. 2004;42:59–66.
  • Komisaruk BR, Mosier KM, Liu WC, Criminale C, Zaborszky L, Whipple B, . Functional localization of brainstem and cervical spinal cord nuclei in humans with fMRI. AJNR Am J Neuroradiol. 2002;23:609–17.
  • Filippi M, Agosta F, Abrahams S, Fazekas F, Grosskreutz J, Kalra S, . European Federation of Neurological Societies. EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol. 2010;17:526 e20.
  • Chen CJ, Hsu HL, Tseng YC, Lyu RK, Chen CM, Huang YC, . Hirayama flexion myelopathy: neutral-position MR imaging findings. Importance of loss of attachment. Radiology. 2004;231:39–44.
  • Schmalbach S, Petri S, Götz F, Dengler R, Krampfl K. Anterior cysts of the spine: a difficult differential diagnosis to amyotrophic lateral sclerosis. J Neurol. 2008;255: 1662–9.
  • Driver-Dunckley ED, Hoxworth JM, Patel NP, Bosch EP, Goodman BP. Superficial siderosis mimicking amyotrophic lateral sclerosis. J Clin Neuromuscul Dis. 2010;11: 137–44.
  • Cercignani M, Horsfield MA, Agosta F, Filippi M. Sensitivity-encoded diffusion tensor MR imaging of the cervical cord. AJNR Am J Neuroradiol. 2003;24:1254–6.
  • Holder CA, Muthupillai R, Mukundan S Jr, Eastwood JD, Hudgins PA. Diffusion weighted MR imaging of the normal human spinal cord in vivo. AJNR Am J Neuroradiol. 2000;21:1799–806.
  • Tsuchiya K, Fujikawa A, Suzuki Y. Diffusion Tractography of the Cervical Spinal Cord by Using Parallel Imaging. AJNR Am J Neuroradiol. 2005;26:398–400.
  • Dadon-Nachum M, Melamed E, Offen D. The ‘dying-back’ phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43:470–7.
  • Davison C. Amyotrophic lateral sclerosis, origin and extent of upper motor neuron lesion. Arch Neurol Psychiatry. 1941;46:1039–56.
  • Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry. 1970;33:338–57.
  • Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, . Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232–40.
  • Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805–11.
  • Henkel JS, Beers DR, Zhao W, Appel SH. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol. 2009;4:389–98.
  • Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253–63.
  • Dibaj P, Steffens H, Zsch ntzsch J, Nadrigny F, Schomburg ED, Kirchhoff F, . In vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS. PLoS One. 2011; 6:e17910.
  • Henkel JS, Engelhardt JI, Sikl s L, Simpson EP, Kim SH, Pan T, . Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55:221–35.
  • Graber DJ, Hickey WF, Harris BT. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J Neuroinflammation. 2010;7:8.
  • Bataveljić D, Djogo N, Zupunski L, Bajicć A, Nicaise C, Pochet R, . Live monitoring of brain damage in the rat model of amyotrophic lateral sclerosis. Gen Physiol Biophys. 2009;28:212–8.
  • Garbuzova-Davis S, Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, Borlongan CV, . Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res. 2011;1398:113 25.
  • Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M. The blood-spinal cord barrier: morphology and clinical implications. Ann Neurol. 2011;70:194–206.
  • Andjus PR, Bataveljić D, Vanhoutte G, Mitrecic D, Pizzolante F, Djogo N, . In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach. Anat Rec. 2009;292:1882–92.
  • Miyazaki K, Ohta Y, Nagai M, Morimoto N, Kurata T, Takehisa Y, . Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res. 2011;89:718–28.
  • Nicaise C, Mitrecic D, Demetter P, de Decker R, Authelet M, Boom A, . Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 2009;1301:152 62.
  • Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modelling ALS. Brain Res. 2007;1157:126 37.
  • Verstraete E, Biessels GJ, van den Heuvel MP, Visser F, Luijten PR, van den Berg LH. No evidence of microbleeds in ALS patients at 7 Tesla MRI. Amyotroph Lateral Scler. 2010;11:555–7.
  • Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of the human motor cortex. Lancet. 1985; 1:1106–7.
  • Eisen A, Weber M. Neurophysiological evaluation of cortical function in the early diagnosis of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl1):S47–51.
  • Ziemann U, Eisen A. TMS for ALS: why and why not. Clin Neurophysiol. 2004;115:1237–8.
  • Rossini PM, Rossi S. Transcranial magnetic stimulation: diagnostic, therapeutic and research potential. Neurology. 2007;68:484–8.
  • Pouget J, Trefouret S, Attarian S. Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl 2):S45–9.
  • Komissarow L, Rollnik JD, Bogdanova D, Krampfl K, Khabirov FA, Kossev A, . Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol. 2004;115:356–60.
  • Rosler KM, Magistris MR. Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol. 2004;115:1715.
  • Argyriou AA, Polychronopoulos P, Talelli P, Chroni E. F-wave study in amyotrophic lateral sclerosis: assessment of balance between upper and lower motor neuron involvement. Clin Neurophysiol. 2006;117:1260–5.
  • Drory VE, Kovach I, Groozman GB. Electrophysiological evaluation of the upper motor neuron involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:147–52.
  • Claus D, Brunholzl C, Kerling FP, Henschel S. Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis. J Neurol Sci. 1995;129(Suppl):30–4.
  • Trompetto C, Caponnetto C, Buccolieri A, Marchese R, Abbruzzese G. Responses of masseter muscles to transcranial magnetic stimulation in patients with amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol. 1998;109:309–14.
  • Mills KR, Nithi KA. Peripheral and central motor conduction in amyotrophic lateral sclerosis. J Neurol Sci. 1998;159:82–7.
  • Triggs WJ, Menkes D, Onorato J, Yan RS, Young MS, Newell K, . Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology. 1999;53:605–11.
  • Schulte-Mattler WJ, M ller T, Zierz S. Transcranial magnetic stimulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis. J Neurol Sci. 1999;170:51–6.
  • Pouget J, Trefouret S, Attarian S. Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS. Amyotroph Lateral Scler. 2000;1(Suppl 2):S45–9.
  • Urban PP, Wicht S, Hopf HC. Sensitivity of transcranial magnetic stimulation of cortico-bulbar vs. cortico-spinal tract involvement in amyotrophic lateral sclerosis (ALS). J Neurol. 2001;248:850–5.
  • Desiato MT, Bernardi G, Hagi HA, Boffa L, Caramia MD. Transcranial magnetic stimulation of motor pathways directed to muscles supplied by cranial nerves in amyotrophic lateral sclerosis. Clin Neurophysiol. 2002;113:132–40.
  • Kaufmann P, Pullman SL, Shungu DC, Chan S, Hays AP, del Bene ML, . Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology. 2004;62:1753–7.
  • Renton AE, Majounie E, Waite A, Sim n-S nchez J, Rollinson S, Gibbs JR, . A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.